Animal models of Parkinson’s disease and L-dopa induced dyskinesia: How close are we to the clinic?

被引：0
|
作者：
Emma Lane
Stephen Dunnett
机构：
[1] Cardiff University,School of Bioscience
来源：
Psychopharmacology | 2008年 / 199卷
关键词：
Parkinson’s disease; L-dopa-induced dyskinesia; 6-OHDA lesioned rat; MPTP-treated primate; Animal models;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：303 / 312
页数：9
相关论文
共 50 条
  • [11] Possible role for chlorpheniramine in the treatment of L-DOPA induced dyskinesia in Parkinson's disease
    Karamanakos, Petros N.
    Pappas, Periklis
    Marselos, Marios
    PHARMACY WORLD & SCIENCE, 2008, 30 (01): : 1 - 2
  • [12] EFFECT OF SEROTONIN TRANSPORTER BLOCKADE ON L-DOPA-INDUCED DYSKINESIA IN ANIMAL MODELS OF PARKINSON'S DISEASE
    Fidalgo, C.
    Ko, W. K. D.
    Tronci, E.
    Li, Q.
    Stancampiano, R.
    Chuan, Q.
    Bezard, E.
    Carta, M.
    NEUROSCIENCE, 2015, 298 : 389 - 396
  • [13] L-DOPA INDUCED DYSKINESIA
    Tursunov, D.
    PARKINSONISM & RELATED DISORDERS, 2020, 79 : E94 - E94
  • [14] The role of GRK6 in animal models of Parkinson's Disease and L-DOPA treatment
    Francesca Managò
    Stefano Espinoza
    Ali Salahpour
    Tatyana D. Sotnikova
    Marc G. Caron
    Richard T. Premont
    Raul R. Gainetdinov
    Scientific Reports, 2
  • [15] Are cyclooxygenase-2 and nitric oxide involved in the dyskinesia of Parkinson's disease induced by L-DOPA?
    Bortolanza, Mariza
    Padovan-Neto, Fernando E.
    Cavalcanti-Kiwiatkoski, Roberta
    dos Santos-Pereira, Mauricio
    Mitkovski, Miso
    Raisman-Vozari, Rita
    Del-Bel, Elaine
    PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2015, 370 (1672) : 1 - 13
  • [16] The role of GRK6 in animal models of Parkinson's Disease and L-DOPA treatment
    Manago, Francesca
    Espinoza, Stefano
    Salahpour, Ali
    Sotnikova, Tatyana D.
    Caron, Marc G.
    Premont, Richard T.
    Gainetdinov, Raul R.
    SCIENTIFIC REPORTS, 2012, 2
  • [17] The combination of oral L-DOPA/rimonabant for effective dyskinesia treatment and cytological preservation in a rat model of Parkinson's disease and L-DOPA-induced dyskinesia
    Gutierrez-Valdez, Ana L.
    Garcia-Ruiz, Ricardo
    Anaya-Martinez, Veronica
    Torres-Esquivel, Carmen
    Espinosa-Villanueva, Jesus
    Reynoso-Erazo, Leonardo
    Tron-Alvarez, Rocio
    Aley-Medina, Patricia
    Sanchez-Betancourt, Javier
    Montiel-Flores, Enrique
    Avila-Costa, Maria R.
    BEHAVIOURAL PHARMACOLOGY, 2013, 24 (08): : 640 - 652
  • [18] Which is a more important risk factor for L-DOPA-induced dyskinesia, age at onset of Parkinson's disease or age at L-DOPA treatment for Parkinson's disease?
    Kimura, Tamaki
    Tomiyama, Masahiko
    Arai, Akira
    Suzuki, Chieko
    Shouji, Mikio
    NEUROSCIENCE RESEARCH, 2008, 61 : S203 - S203
  • [19] The Pharmacology of L-DOPA-Induced Dyskinesia in Parkinson's Disease
    Huot, Philippe
    Johnston, Tom H.
    Koprich, James B.
    Fox, Susan H.
    Brotchie, Jonathan M.
    PHARMACOLOGICAL REVIEWS, 2013, 65 (01) : 171 - 222
  • [20] ASSESSMENT OF L-DOPA INDUCED DYSKINESIA
    Assatullaev, G.
    PARKINSONISM & RELATED DISORDERS, 2020, 79 : E103 - E103
12345